Cutting-edge solutions for proton therapy
Together, Philips and IBA offer a full range of innovative oncology solutions, advancing clinical capability. These include:
- CT: The Philips IQon features the world’s first spectral detector CT.
- PET/CT: The Philips Vereos is the first digital whole body PET/CT system, the next level in molecular imaging. The Ingenuity TF PET/CT has excellent contrast and spatial resolution, enhancing lesion detectability.
- MR: As the first digital MR system, Philips Ingenia (1.5T and 3.0T) with its revolutionary dStream architecture delivers accelerated performance with digital clarity and speed.
- ProteusONE: IBA’s compact single-room proton therapy solution can be easily installed into many kinds of healthcare settings. ProteusONE delivers the latest advance in proton radiation therapy, Intensity Modulated Proton Therapy (IMPT) – combining the precise dose delivery of Pencil Beam Scanning (PBS) with the dimensionally accurate imaging of 3D Cone Beam Computed Tomography (CBCT), enabling physicians to truly track where protons will be targeting tumor cells.
- An excellent patient experience: Cancer patients are submited to multiple diagnostic and treatment procedures with an understandable level of fear An environment designed with the patient at the center can make a real difference in their experience and state of mind. Philips Ambient Experience technology transforms imaging and treatment suites into soothing, entertaining and even educational spaces.
- Planning tools: Planning plays a central role in influencing treatment confidence as well as departmental workflow. Delivering sophisticated treatment techniques that are both efficient and reliable can be challenging. Philips Pinnacle3 treatment planning software is a suite of simple, intuitive tools to plan the most sophisticated oncology treatment.
- IntelliSpace Portal: Philips IntelliSpace Portal combines high-quality images, advanced analysis, and workflow efficiency tools into a single advanced analysis solution. In addition, the Portal’s Multimodality Tumor Tracking helps clinicians evaluate change in tumor activity or size over time to determine treatment effectiveness or assist with diagnosis and tumor staging.